Can we Use Resting-state fMRI and CSD Fiber Tractography for Presurgical Mapping?
Conditions:   Brain Tumor;   Brain Pathology;   Epilepsy;   Vascular Malformations, Brain Intervention:   Sponsor:   Universitaire Ziekenhuizen KU Leuven Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 15, 2023 Category: Research Source Type: clinical trials

Prospective Evaluation of AI R & D Tool in Adult Glioma and Other Primary Brain Tumours (PEAR-GLIO)
Conditions:   Brain Tumor;   Glioma, Malignant;   Ependymoma;   Oligodendroglioma;   Glioblastoma Intervention:   Procedure: Resection Sponsors:   Ourotech, Inc.;   Imperial College Healthcare NHS Trust Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 15, 2023 Category: Research Source Type: clinical trials

Can we Use Resting-state fMRI and CSD Fiber Tractography for Presurgical Mapping?
Conditions:   Brain Tumor;   Brain Pathology;   Epilepsy;   Vascular Malformations, Brain Intervention:   Sponsor:   Universitaire Ziekenhuizen KU Leuven Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 15, 2023 Category: Research Source Type: clinical trials

Prospective Evaluation of AI R & D Tool in Adult Glioma and Other Primary Brain Tumours (PEAR-GLIO)
Conditions:   Brain Tumor;   Glioma, Malignant;   Ependymoma;   Oligodendroglioma;   Glioblastoma Intervention:   Procedure: Resection Sponsors:   Ourotech, Inc.;   Imperial College Healthcare NHS Trust Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 15, 2023 Category: Research Source Type: clinical trials

Non-small Cell Lung Cancer With Central Nervous System Metastasis
Condition:   Lung Cancer With Central Nervous System Metastasis Intervention:   Other: lung cancer with brain /leptomeningeal metastasis Sponsor:   National Taiwan University Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 7, 2023 Category: Research Source Type: clinical trials

Tucatinib With Brain and/or Spinal XRT in Patients With HER2+ Metastatic Breast Cancer and LMD
Conditions:   HER2-positive Breast Cancer;   LMD Interventions:   Drug: Tucatinib 150 MG;   Drug: Trastuzumab;   Drug: Capecitabine;   Radiation: Brain & Spinal Radiation Sponsors:   Sunnybrook Health Sciences Centre;   Seagen Inc.;   Viatris Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 29, 2023 Category: Research Source Type: clinical trials

Efficacy and Safety of Disitamab Vedotin Plus Pyrotinib or Naratinib in HER2-positive Breast Cancer Patients With Brain Metastasis
Condition:   Breast Cancer Intervention:   Drug: Disitamab Vedotin plus pyrotinib or naratinib Sponsor:   Xi'an International Medical Center Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 29, 2023 Category: Research Source Type: clinical trials